CDC- BRFSS – ACBS 2020 Adult Prevalence Table 7

Table 7: Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2020.
State/Territory Current
Sample
size±
% SE§ 95% CI
Arizona 315 30.0 4.0 (22.2 – 37.8)
Connecticut 297 29.2 4.2 (21.0 – 37.4)
Florida 281 23.1 4.7 (13.9 – 32.3)
Georgia 274 32.5 4.8 (23.1 – 41.9)
Hawaii 232 31.5 4.2 (23.3 – 39.7)
Indiana 290 30.5 3.5 (23.6 – 37.4)
Iowa 279 34.1 3.6 (27.0 – 41.2)
Kansas 223 23.9 3.5 (17.0 – 30.8)
Maine 391 33.2 4.2 (25.0 – 41.4)
Maryland 148 29.6 5.2 (19.4 – 39.8)
Massachusetts 234 31.8 4.4 (23.2 – 40.4)
Michigan 328 34.3 3.5 (27.4 – 41.2)
Minnesota 476 28.6 2.5 (23.7 – 33.5)
Missouri 254 32.6 4.3 (24.2 – 41.0)
Montana 235 29.8 3.7 (22.5 – 37.1)
Nebraska 420 34.4 3.7 (27.1 – 41.7)
New Hampshire 375 31.7 3.3 (25.2 – 38.2)
New Jersey 446 29.9 2.8 (24.4 – 35.4)
New Mexico 244 27.2 4.6 (18.2 – 36.2)
New York 179 34.6 4.8 (25.2 – 44.0)
Ohio 408 27.1 3.3 (20.6 – 33.6)
Oregon 232 30.4 3.6 (23.3 – 37.5)
Pennsylvania 178 30.0 4.4 (21.4 – 38.6)
Rhode Island 235 37.6 4.8 (28.2 – 47.0)
Texas 390 31.5 4.9 (21.9 – 41.1)
Utah 364 22.6 2.5 (17.7 – 27.5)
Vermont 377 28.3 3.2 (22.0 – 34.6)
Wisconsin 227 34.2 4.2 (26.0 – 42.4)
Puerto Rico 221 17.6 3.7 (10.3 – 24.9)
29 States / Area 8,553 30.4 1.0 (28.4 – 32.4)
Median 30.4
Range 17.6-37.6

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

± Sample size for adults with current asthma, excludes “DK/Refused”

§ Standard error

Confidence interval

Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2020/pdf/sdq_report_acbs_20-508.pdf